Cargando…

Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction

Voiding dysfunction due to detrusor underactivity or urethral sphincter dysfunction is a treatment challenge for urologists. Recently, urologists have used botulinum toxin A (BoNT-A) injection into the urethral sphincter to treat voiding dysfunction. This treatment has been found to decrease urethra...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kuo, Hann-Chorng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442911/ https://www.ncbi.nlm.nih.gov/pubmed/28757732 http://dx.doi.org/10.1016/j.tcmj.2016.07.001

Ejemplares similares

Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions
por: Lee, Yu-Khun, et al.
Publicado: (2019)

Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction
por: Kao, Yao-Lin, et al.
Publicado: (2019)

OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction – A Randomized, Double-Blind, Placebo-Controlled Study
por: Jiang, Yuan-Hong, et al.
Publicado: (2016)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
por: Lee, Cheng-Ling, et al.
Publicado: (2022)

Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?
por: Chen, Sheng-Fu, et al.
Publicado: (2023)

Botulinum Toxin A Injection for Autonomic Dysreflexia—Detrusor Injection or Urethral Sphincter Injection?
por: Chow, Po-Ming, et al.
Publicado: (2023)

Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors
por: Ou, Yin-Chien, et al.
Publicado: (2021)

Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection
por: Kao, Yao-Lin, et al.
Publicado: (2022)

Voiding Dysfunction Due to Urethral Sphincter Dysfunction Might Be an Early Neurological Presentation of Central Nervous System Disorders in Aged Patients
por: Ho, Guan-Ru, et al.
Publicado: (2023)

A novel management for postprostatectomy urinary incontinence: platelet-rich plasma urethral sphincter injection
por: Lee, Ping-Jui, et al.
Publicado: (2021)

The Efficacy and Mid-term Durability of Urethral Sphincter Injections of Platelet-Rich Plasma in Treatment of Female Stress Urinary Incontinence
por: Chiang, Ching-Hsiang, et al.
Publicado: (2022)

Therapeutic Efficacy of Urethral Sphincter Injections of Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency: A Proof-of-Concept Clinical Trial
por: Jiang, Yuang-Hong, et al.
Publicado: (2021)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Therapeutic Efficacy and Mid-Term Durability of Urethral Sphincter Platelet-Rich Plasma Injections to Treat Postprostatectomy Stress Urinary Incontinence
por: Lee, Ping-Jui, et al.
Publicado: (2022)

Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated
por: Chen, Po-Cheng, et al.
Publicado: (2023)

Neurogenic inflammation: with additional discussion of central and perceptual integration of nonneurogenic inflammation.
por: Bascom, R, et al.
Publicado: (1997)

Videourodynamic Studies of Women with Voiding Dysfunction
por: Hsiao, Sheng-Mou, et al.
Publicado: (2017)

AB200. Treatment effect of TURP plus urethral sphincter botox A injection on male neurogenic micturition dysfunction
por: Huang, Xiao, et al.
Publicado: (2016)

Satisfaction with Surgical Procedures and Bladder Management of Chronic Spinal Cord Injured Patients with Voiding Dysfunction Who Desire Spontaneous Voiding
por: Wu, Shu-Yu, et al.
Publicado: (2022)

Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction
por: Yang, Tsai-Hwa, et al.
Publicado: (2018)

Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence
por: Murata, Yasutaka, et al.
Publicado: (2022)

Transurethral Incision of the Bladder Neck with or without Additional Procedure Resumes Spontaneous Voiding in Female Voiding Dysfunction—A Long-Term Retrospective Follow-Up
por: Ong, Hueih-Ling, et al.
Publicado: (2023)

Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Lee, Young-Suk, et al.
Publicado: (2018)

Efficacy and safety of botulinum toxin a injection into urethral sphincter for underactive bladder
por: Chen, Guoqing, et al.
Publicado: (2019)

Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?
por: Kim, Shannon HK, et al.
Publicado: (2016)

Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction
por: Wei, Pengxu
Publicado: (2022)

Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding
por: Chiang, Ching-Hsiang, et al.
Publicado: (2021)

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
por: Jhang, Jia-Fong, et al.
Publicado: (2016)

Long-Term Follow-Up of Lower Urinary Tract Outcome in Children with Dysfunctional Voiding
por: Peng, Chung-Hsin, et al.
Publicado: (2022)

Use of botulinum toxin for voiding dysfunction
por: Eldred-Evans, David, et al.
Publicado: (2017)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2020)

Diagnostic and prognostic value of urine biomarkers among women with dysfunctional voiding
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery
por: Lee, Hsiang-Ying, et al.
Publicado: (2023)

Delivery of urethral sphincter botulinum toxin injections for treating urinary retention during the COVID19 pandemic
por: Wright, Sarah L., et al.
Publicado: (2023)

Urodynamic prognostic factors for large post-void residual urine volume after intravesical injection of onabotulinumtoxinA for overactive bladder
por: Hsiao, Sheng-Mou, et al.
Publicado: (2017)

Dermatologist and urologist? A neglected relationship in neurogenic voiding dysfunctions
por: Przydacz, Mikolaj, et al.
Publicado: (2017)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

CONCOMITANT DETRUSOR AND EXTERNAL URETHRAL SPHINCTER BOTULINUM TOXIN-A INJECTIONS IN MALE SPINAL CORD INJURY PATIENTS WITH DETRUSOR OVERACTIVITY AND DETRUSOR SPHINCTER DYSSYNERGIA
por: HUANG, Yu-Hui, et al.
Publicado: (2022)

Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
por: Chen, Sheng-Fu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k912d4rri88783rra3bsg99dtp